Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.34% |
| 2 | Technology | 16.84% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBSE
3751
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $32K | ﹤0.01% |
8,631
-5,630
| -39% | -$26K |
|
|
IRNT
3752
DELISTED
IronNet, Inc.
IRNT
| $32K | ﹤0.01% |
90,767
+77,908
| +606% | +$30.7K |
|
3753
Focus Universal
FCUV
$8.15M
| $31K | ﹤0.01% |
+31
| New | +$44.8K |
|
|
PTN
3754
Palatin Technologies
PTN
$13.7M
| $31K | ﹤0.01% |
227
-64
| -22% | -$10.6K |
|
|
AVGR
3755
DELISTED
Avinger, Inc. Common Stock
AVGR
| $31K | ﹤0.01% |
2,518
+273
| +12% | +$4.72K |
|
|
IMH
3756
DELISTED
Impac Mortgage Holdings Inc.
IMH
| $31K | ﹤0.01% |
87,871
+4,600
| +6% | +$1.61K |
|
3757
BioCardia
BCDA
$12.3M
| $30K | ﹤0.01% |
1,040
+100
| +11% | +$3.32K |
|
|
CASI
3758
DELISTED
CASI Pharmaceuticals
CASI
| $30K | ﹤0.01% |
13,100
+2,200
| +20% | +$4.24K |
|
3759
Prenetics Global
PRE
$317M
| $30K | ﹤0.01% |
+2,053
| New | +$39.4K |
|
3760
TOMI Environmental Solutions
TOMZ
$12.3M
| $30K | ﹤0.01% |
15,167
+4,300
| +40% | +$8.97K |
|
3761
Vivos Therapeutics
VVOS
$5.7M
| $30K | ﹤0.01% |
3,556
+2,916
| +456% | +$63.8K |
|
|
TMBR
3762
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
| $30K | ﹤0.01% |
+17,700
| New | +$40.1K |
|
3763
Onfolio Holdings
ONFO
$556K
| $29K | ﹤0.01% |
+18,375
| New | +$32.6K |
|
3764
Socket Mobile
SCKT
$3.32M
| $29K | ﹤0.01% |
15,700
+1,300
| +9% | +$2.79K |
|
|
KBNT
3765
DELISTED
Kubient, Inc. Common Stock
KBNT
| $29K | ﹤0.01% |
41,496
+1,000
| +2% | +$807 |
|
3766
Candel Therapeutics
CADL
$733M
| $28K | ﹤0.01% |
+21,000
| New | +$41K |
|
3767
Equillium
EQ
$139M
| $28K | ﹤0.01% |
38,700
+16,200
| +72% | +$15.5K |
|
3768
LifeMD
LFMD
$169M
| $28K | ﹤0.01% |
16,500
+5,500
| +50% | +$9.71K |
|
|
ZENV
3769
DELISTED
Zenvia
ZENV
| $28K | ﹤0.01% |
28,000
+16,700
| +148% | +$18.4K |
|
|
BPTH
3770
DELISTED
Bio-Path Holdings Inc
BPTH
| $28K | ﹤0.01% |
1,015
+55
| +6% | +$1.98K |
|
|
SONX
3771
DELISTED
Sonendo, Inc.
SONX
| $28K | ﹤0.01% |
14,100
+3,400
| +32% | +$7.71K |
|
3772
CNS Pharmaceuticals
CNSP
$8.5M
| $27K | ﹤0.01% |
+1
| New | +$56K |
|
3773
FingerMotion
FNGR
$16.6M
| $27K | ﹤0.01% |
+18,000
| New | +$45.8K |
|
|
FURY
3774
Fury Gold Mines
FURY
$102M
| $27K | ﹤0.01% |
50,177
-72,547
| -59% | -$43K |
|
|
QTEX
3775
QTREX Quantum
QTEX
$50.1M
| $27K | ﹤0.01% |
+20,200
| New | +$30.1K |
|
Similar funds
Renaissance Technologies's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
- Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.